Tumor Board Tuesday
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Tumor Board Tuesday
Jun 21, 2024, 09:30 |
Blog
Choosing therapies for hormone-sensitive metastatic prostate cancer - Tumor Board Tuesday
Tumor Board Tuesday shared on X: "We are waking up to a prepare for a…
May 6, 2024, 09:26 |
Insight
Johnathan Ebben: 3 major subtypes of paraganglioma
Johnathan Ebben, Oncology Fellow at the University of Wisconsin-Madison, shared on X/Twitter: "Tumor Board Tuesday…
May 5, 2024, 22:49 |
Blog
Rachel Riechelm and Álvaro Lopes de Oliveira discuss paragangliomas and pheochromocytoma - Tumor Board Tuesday
Tumor Board Tuesday shared on X: “No Tumor Board Tuesday this past week, so we're…
Apr 16, 2024, 14:54 |
Insight
Treatment of lung cancer is changing! - Tumor Board Tuesday
Tumor Board Tuesday shared on X/Twitter: "Tumor Board Tuesday Treatment of lung cancer is changing!…
Mar 12, 2024, 00:16 |
Blog
The Oscar goes to EV-pembro in metastatic bladder cancer! - Tumor Board Tuesday
Tumor Board Tuesday published the following post on X: "The Oscar goes to EV-pembro in…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube